ondansetron
Tradename Zofran
Manufacturer Glaxo
Treatment Class Psychopharmacologic and Neurologic (CNS)
Indication Chemotherapy-induced vomiting
MSB Review: Granisetron Approved for Chemotherapy-induced Vomiting
MSB Review: Oral Ondansetron Indication Expanded to Post-Op Nausea and
Vomiting
MSB Review: Dolasetron for Chemotherapy-induced Nausea
PNN Review Droperidol Similar to Ondansetron for PONV
oprelvekin
Tradename Neumega
Manufacturer Genetics Institute
Treatment Class Cardiovascular
Indication Prevention of severe thrombocytopenia and the reduction of the
need for platelet transfusion following myelosuppressive chemotherapy
MSB Review: Oprelvekin for Prevention of Severe Thrombocytopenia
paclitaxel
Tradename Taxol
Manufacturer Bristol-Myers Squibb
Treatment Class Oncology
Indication Breast, Ovarian Cancer
Graphic Chemical structure
DrugPR: NEW TAXOL REGIMEN SIGNIFICANTLY INCREASES A WOMAN'S CHANCES FOR
BREAST CANCER CURE
MSB Review Semisynthetic Taxol Approved for Breast, Ovarian Cancer
MSB Review Paclitaxel Plus Carboplatin Shows Promise in Advanced NSCLC
MSB Review: Topotecan Approved for Ovarian Cancer
PNN Review Breast Cancer Symposium Opens in San Antonio
pegaspargase
Tradename Oncaspar
Manufacturer Rhone-Poulenc Rorer
Treatment Class Oncology
Indication Acute Lymphoblastic Leukemia
MSB Review Pegasparagase Approved for Acute Lymphoblastic Leukemia
pilocarpine hydrochloride
Tradename Salagen
Manufacturer MGI Pharma
Treatment Class Oncology
Indication Radiation-induced dry mouth (xerostomia)
MSB Review Oral Pilocarpine Hydrochloride for Radiation-induced Dry Mouth
porfimer sodium
Tradename Photofrin
Manufacturer Sanofi
Treatment Class Oncology
Indication esophageal cancer; Palliative management of advanced esophageal
cancer and microinvasive endobronchial nonsmall cell lung cancer in
patients for whom surgery or radiotherapy is not an option
MSB Review Photofrin Recommended as Palliative for Esophageal Cancer
MSB Review: Porfimer Approved for Esophageal Cancer Obstructions
MSB Review: Porfimer: A Novel Approach to the Management of in situ Cancers
PNN: Light-Activated Porfimer Approved for Lung Cancer
vinorelbine tartrate
Manufacturer Burroughs Wellcome
Tradename Navelbine
Treatment Class Oncology
Indication Non-small-cell Lung Cancer
MSB Review: Vinorelbine Recommended for Non-Small-Cell Lung Cancer
MSB Review: Vinorelbine Approved for Advanced Lung Cancer
DrugPR: TAXOTERE(R)/NAVELBINE(R) COMBINATION THERAPY DEMONSTRATES PROMISING
ACTIVITY IN ADVANCED BREAST CANCER
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
